Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31false22024-01-01false2No description of principal activitytrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 07891954 2024-01-01 2024-12-31 07891954 2023-01-01 2023-12-31 07891954 2024-12-31 07891954 2023-12-31 07891954 c:Director1 2024-01-01 2024-12-31 07891954 d:FurnitureFittings 2024-01-01 2024-12-31 07891954 d:FurnitureFittings 2024-12-31 07891954 d:FurnitureFittings 2023-12-31 07891954 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 07891954 d:CurrentFinancialInstruments 2024-12-31 07891954 d:CurrentFinancialInstruments 2023-12-31 07891954 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 07891954 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 07891954 d:ShareCapital 2024-12-31 07891954 d:ShareCapital 2023-12-31 07891954 d:RetainedEarningsAccumulatedLosses 2024-12-31 07891954 d:RetainedEarningsAccumulatedLosses 2023-12-31 07891954 c:FRS102 2024-01-01 2024-12-31 07891954 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 07891954 c:FullAccounts 2024-01-01 2024-12-31 07891954 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07891954 2 2024-01-01 2024-12-31 07891954 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure
Registered number: 07891954














MEDWAY HAEMATOLOGY PRACTICE LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 DECEMBER 2024

 
MEDWAY HAEMATOLOGY PRACTICE LIMITED
REGISTERED NUMBER: 07891954

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note

Fixed assets
  

Tangible assets
  
3,328
3,629

  
3,328
3,629

Current assets
  

Debtors: amounts falling due within one year
  
24,034
3,695

Cash at bank and in hand
  
375,880
402,477

  
399,914
406,172

Creditors: amounts falling due within one year
  
(11,628)
(30,974)

Net current assets
  
 
 
388,286
 
 
375,198

Total assets less current liabilities
  
391,614
378,827

  

Net assets
  
£391,614
£378,827


Capital and reserves
  

Called up share capital 
  
10
10

Profit and loss account
  
391,604
378,817

  
£391,614
£378,827


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 5 June 2025.




___________________________
Dr Maadh Aldouri
Director
Page 1

 
MEDWAY HAEMATOLOGY PRACTICE LIMITED
REGISTERED NUMBER: 07891954

BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024


The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
MEDWAY HAEMATOLOGY PRACTICE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Medway Haematology Practice Limited is a private company limited by shares and incorporated in England and Wales. The company registration number is 07891954. the registered office for the company is Henwood House, Henwood, Ashford, Kent, TN24 8DH. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
MEDWAY HAEMATOLOGY PRACTICE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
4%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
MEDWAY HAEMATOLOGY PRACTICE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

2024
2023

Wages and salaries
9,964
12,570

Cost of defined contribution scheme
40,000
40,000

£49,964
£52,570


The average monthly number of employees, including directors, during the year was 2 (2023 -2).


4.


Tangible fixed assets





Fixtures and fittings



Cost or valuation


At 1 January 2024
7,527



At 31 December 2024

7,527



Depreciation


At 1 January 2024
3,898


Charge for the year on owned assets
301



At 31 December 2024

4,199



Net book value



At 31 December 2024
£3,328



At 31 December 2023
£3,629

Page 5

 
MEDWAY HAEMATOLOGY PRACTICE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Debtors

2024
2023


Trade debtors
3,312
3,695

Other debtors
20,222
-

Prepayments and accrued income
500
-

£24,034
£3,695



6.


Cash and cash equivalents

2024
2023

Cash at bank and in hand
£375,880
£402,477



7.


Creditors: Amounts falling due within one year

2024
2023

Corporation tax
9,051
13,288

Other creditors
-
15,346

Accruals and deferred income
2,577
2,340

£11,628
£30,974



Page 6